Similar articles

• Dialysis: vascular access: not enough light at the end of the tunnel?

  Vanholder R, Verbeke F, Van Biesen W. Vanholder R, et al. Nat Rev Nephrol. 2009 Oct;5(10):551-2. doi: 10.1038/nrneph.2009.144. Nat Rev Nephrol. 2009. PMID: 19776771 No abstract available.
• Pharmacologic intervention to prevent hemodialysis vascular access thrombosis.

  Diskin CJ, Stokes TJ Jr, Pennell AT. Diskin CJ, et al. Nephron. 1993;64(1):1-26. doi: 10.1159/000187272. Nephron. 1993. PMID: 8502311 No abstract available.
• Coagulation and haemodialysis access thrombosis.

  Smits JH, van der Linden J, Blankestijn PJ, Rabelink TJ. Smits JH, et al. Nephrol Dial Transplant. 2000 Nov;15(11):1755-60. doi: 10.1093/ndt/15.11.1755. Nephrol Dial Transplant. 2000. PMID: 11071961 Review. No abstract available.
• Is hyperhomocysteinaemia a risk factor for recurrent vascular access thrombosis in haemodialysis patients?

  Ducloux D, Pascal B, Jamali M, Gibey R, Chalopin JM. Ducloux D, et al. Nephrol Dial Transplant. 1997 Sep;12(9):2037-8. doi: 10.1093/oxfordjournals.ndt.a027791. Nephrol Dial Transplant. 1997. PMID: 9306379 No abstract available.
• Antithrombotic agents and the prevention of access thrombosis.

  Kaufman JS. Kaufman JS. Semin Dial. 2000 Jan-Feb;13(1):40-6. doi: 10.1046/j.1525-139x.2000.00012.x. Semin Dial. 2000. PMID: 10740671 Review. No abstract available.